In 2016, Chengdu Shengnuo Biotechnology Co., Ltd. signed the service of Uneed Union Information Integration Platform. Sales in 2017 were 180 million, sales in 2018 were 290 million, sales in 2019 were expected to exceed 400 million, annual profit growth remained two-digit.

Relevant person in charge said: “The company has been on the road of innovation and internationalization. We are very optimistic about the innovative products, advanced technology and international service level of Uneed. It can not only provide fast, accurate and efficient management and support for the company to complete drug marketing, but also provide in-depth insight and decision-making reference for enterprises to prevent risks. We are looking forward to more cooperation with Uneed.”